↓ Skip to main content

Dove Medical Press

Safe medication use based on knowledge of information about contraindications concerning cross allergy and comprehensive clinical intervention

Overview of attention for article published in Therapeutics and Clinical Risk Management, February 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
46 Mendeley
Title
Safe medication use based on knowledge of information about contraindications concerning cross allergy and comprehensive clinical intervention
Published in
Therapeutics and Clinical Risk Management, February 2013
DOI 10.2147/tcrm.s42013
Pubmed ID
Authors

Wei Li, Ling-Ling Zhu, Quan Zhou

Abstract

An investigation of safety issues regarding information on contraindications related to cross allergy was conducted to promote clinical awareness and prevent medical errors in a 2200-bed tertiary care teaching hospital.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Finland 1 2%
Egypt 1 2%
Unknown 44 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 17%
Researcher 7 15%
Student > Ph. D. Student 7 15%
Student > Doctoral Student 5 11%
Student > Bachelor 4 9%
Other 9 20%
Unknown 6 13%
Readers by discipline Count As %
Psychology 8 17%
Medicine and Dentistry 6 13%
Business, Management and Accounting 4 9%
Nursing and Health Professions 4 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 9%
Other 10 22%
Unknown 10 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 February 2013.
All research outputs
#20,823,121
of 25,584,565 outputs
Outputs from Therapeutics and Clinical Risk Management
#1,050
of 1,308 outputs
Outputs of similar age
#230,894
of 292,111 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#6
of 8 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,308 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.8. This one is in the 10th percentile – i.e., 10% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 292,111 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.